Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 66

Results For "immuno"

751 News Found

Lupin enters the diagnostics business
Clinical Trials | December 10, 2021

Lupin enters the diagnostics business

Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.


USFDA authorises Astra’s antibody cocktail to prevent Covid
Drug Approval | December 09, 2021

USFDA authorises Astra’s antibody cocktail to prevent Covid

Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19


Biocon Pharma receives ANDA approval for Mycophenolic acid
Drug Approval | December 03, 2021

Biocon Pharma receives ANDA approval for Mycophenolic acid

This further adds to Biocon’s portfolio of vertically integrated complex drug products


U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
Biotech | November 26, 2021

Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron

The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease


Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines
Biotech | November 26, 2021

Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines

This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs


Merck showcases potential for several cancers, MS and lupus
News | November 22, 2021

Merck showcases potential for several cancers, MS and lupus

Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline


AstraZeneca’s Covid-19 drug offers 83% protection over six months
Biotech | November 18, 2021

AstraZeneca’s Covid-19 drug offers 83% protection over six months

Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths